Design of microencapsulated carbon nanotube-based microspheres and its application in colon targeted drug delivery

Drug Delivery

Volumn 21, Issue 2, 2014, Pages 101-109

  Zhou, Min ^a,b   Peng, Zheng ^a   Liao, Shuangquan ^b   Li, Puwang ^a   Li, Sidong ^c  

^a CATAS   (China)

^b HAINAN UNIVERSITY   (China)

^c GUANGDONG OCEAN UNIVERSITY   (China)

Author keywords

Carbon nanotubes; Colon drug delivery; Eudragit; Irinotecan; Microencapsulation

Indexed keywords

CHITOSAN; EUDRAGIT; FOLIC ACID; IRINOTECAN; MICROSPHERE; MULTI WALLED NANOTUBE; OIL;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; COLON; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EVAPORATION; IN VITRO STUDY; MICROENCAPSULATION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE; SYNTHESIS;

CELL SURVIVAL; COLON; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HT29 CELLS; HUMANS; MICROSPHERES; NANOTUBES, CARBON; PARTICLE SIZE;

EID: 84896805251     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.834413     Document Type: Article

References (24)

1. Ali-Boucetta H, Al-Jamal KT, McCarthy D, et al. (2008). Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 4:459-61.
2. Belyanskaya L, Manser P, Spohn P, et al. (2007). The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 45:2643-8.
3. Bianco A, Kostarelos K, Prato M. (2005). Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674-9.
4. Chourasia M, Jain S. (2004). Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 11:201-7.
5. Jose S, Dhanya K, Cinu T, et al. (2009). Colon targeted drug delivery: different approaches. J Young Pharm 1:13-19.
6. Kam NWS, Jessop TC, Wender PA, et al. (2004). Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 126:6850-1.
7. Lay CL, Liu HQ, Tan HR, et al. (2010). Delivery of paclitaxel by physically loading onto poly (ethylene glycol)(PEG)-graftcarbon nanotubes for potent cancer therapeutics. Nanotechnology 21: 5101-4.
8. Li P, Wang Y, Chen L, et al. (2011). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29. Carbohyd Res 346:801-6.
9. Liu Z, Davis C, Cai W, et al. (2008). Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 105: 1410-15.
10. Lorenzo-Lamosa M, Remunan-Lopez C, Vila-Jato J, et al. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 52:109-18.
11. Paharia A, Yadav AK, Rai G, et al. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech 8:87-93.
12. Patel HK, Nagle A, Murthy R. (2008). Characterization of calcium alginate beads of 5-fluorouracil for colon delivery. Asian J Pharmaceut 2:241-5.
13. Peng Z, Feng C, Luo Y, et al. (2010). Self-assembled natural rubber/ multi-walled carbon nanotube composites using latex compounding techniques. Carbon 48:4497-503.
14. Peppas N. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceut Acta Helvet 60:110-11.
15. Philip AK, Philip B. (2010). Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 25:79-87.
16. Rodr?guez M, Vila-Jato JL, Torres D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 55:67-77.
17. Sayes CM, Liang F, Hudson JL. (2006). Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161:135-42.
18. Shivani N, Hetal P, Rajesh K, et al. (2011). Colon delivery of 5-fluoro uracil using cross-linked chitosan microspheres coated with eudragit S 100. Int J Drug Deliv 3:260-8.
19. Siegel R, Ward E, Brawley O, et al. (2011). Cancer statistics, 2011. CA: Cancer J Clinicians 61:212-36.
20. Thakral NK, Ray AR, Majumdar DK. (2010). Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. J Mater Sci-Mater Med 21:2691-9.
21. Vanhoefer U, Harstrick A, Achterrath W, et al. (2001). Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol 19: 1501-18.
22. Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1-15.
23. Zhang H, Alsarra IA, Neau SH. (2002). An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharmaceut 239:197-205.
24. Zhang J, Misra RDK. (2007). Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater 3: 838-50.